Literature DB >> 15910955

"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.

John S Yudkin1, Etto Eringa, Coen D A Stehouwer.   

Abstract

Adipose tissue expresses cytokines that inhibit insulin signalling pathways in liver and muscle. Obesity also results in impairment of endothelium-dependent vasodilatation in response to insulin. We propose a vasoregulatory role for local deposits of fat around the origin of arterioles supplying skeletal muscle. Isolated first-order arterioles from rat cremaster muscle are under dual regulation by insulin, which activates both endothelin-1 mediated vasoconstriction and nitric-oxide-mediated vasodilatation. In obese rat arterioles, insulin-stimulated NO synthesis is impaired, resulting in unopposed vasoconstriction. We propose that this vasoconstriction is the consequence of production of the adipocytokine tumour necrosis factor alpha from the cuff of fat seen surrounding the origin of the arteriole in obese rats--a depot to which we ascribe a specialist vasoregulatory role. We suggest that this cytokine accesses the nutritive vascular tree to inhibit insulin-mediated capillary recruitment--a mechanism we term "vasocrine" signalling. We also suggest a homology between this vasoactive periarteriolar fat and both periarterial and visceral fat, which may explain relations between visceral fat, insulin resistance, and vascular disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910955     DOI: 10.1016/S0140-6736(05)66585-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  164 in total

1.  Perivascular visceral adipose tissue induces atherosclerosis in apolipoprotein E deficient mice.

Authors:  M K Öhman; W Luo; H Wang; C Guo; W Abdallah; H M Russo; D T Eitzman
Journal:  Atherosclerosis       Date:  2011-07-20       Impact factor: 5.162

Review 2.  Muscle microvasculature's structural and functional specializations facilitate muscle metabolism.

Authors:  Yvo H A M Kusters; Eugene J Barrett
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-29       Impact factor: 4.310

3.  Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Joseph M Massaro; Udo Hoffmann; Ian H DeBoer; Sander J Robins; Ramachandran S Vasan; Caroline S Fox
Journal:  Obesity (Silver Spring)       Date:  2010-12-23       Impact factor: 5.002

Review 4.  The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.

Authors:  Michaela Diamant; Maarten E Tushuizen
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

5.  Insulin resistance in pulmonary arterial hypertension.

Authors:  R T Zamanian; G Hansmann; S Snook; D Lilienfeld; K M Rappaport; G M Reaven; M Rabinovitch; R L Doyle
Journal:  Eur Respir J       Date:  2008-12-01       Impact factor: 16.671

Review 6.  Epicardial adipose tissue in endocrine and metabolic diseases.

Authors:  Gianluca Iacobellis
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

Review 7.  Epicardial and thoracic fat - Noninvasive measurement and clinical implications.

Authors:  Damini Dey; Ryo Nakazato; Debiao Li; Daniel S Berman
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

8.  PET/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesions' formation?

Authors:  Tomasz Mazurek; Małgorzata Kobylecka; Magdalena Zielenkiewicz; Aleksandra Kurek; Janusz Kochman; Krzysztof J Filipiak; Krzysztof Mazurek; Zenon Huczek; Leszek Królicki; Grzegorz Opolski
Journal:  J Nucl Cardiol       Date:  2016-03-07       Impact factor: 5.952

9.  Adipokines disrupt cardiac differentiation and cardiomyocyte survival.

Authors:  Laura M Pérez; Beatriz de Lucas; Aurora Bernal; Beatriz G Gálvez
Journal:  Int J Obes (Lond)       Date:  2019-09-23       Impact factor: 5.095

10.  STAT4 contributes to adipose tissue inflammation and atherosclerosis.

Authors:  A D Dobrian; M A Hatcher; J J Brotman; E V Galkina; P Taghavie-Moghadam; H Pei; B A Haynes; J L Nadler
Journal:  J Endocrinol       Date:  2015-08-18       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.